TY - JOUR AU - Forrest, C. B. AU - Bartek, R. J. AU - Rubinstein, Y. AU - Groft, S. C. PY - 2011 DA - 2011// TI - The case for a global rare-diseases registry JO - Lancet VL - 377 UR - https://doi.org/10.1016/S0140-6736(10)60680-0 DO - 10.1016/S0140-6736(10)60680-0 ID - Forrest2011 ER - TY - JOUR AU - van der Lee, J. H. AU - Tanck, M. W. AU - Wesseling, J. AU - Offringa, M. PY - 2009 DA - 2009// TI - Pitfalls in the design and analysis of paediatric clinical trials: a case of a ‘failed’ multi-centre study, and potential solutions JO - Acta Paediatr VL - 98 UR - https://doi.org/10.1111/j.1651-2227.2008.01048.x DO - 10.1111/j.1651-2227.2008.01048.x ID - van der Lee2009 ER - TY - JOUR AU - Nikolakopoulos, S. AU - Roes, K. C. AU - van der Lee, J. H. AU - van der Tweel, I. PY - 2014 DA - 2014// TI - Sample size calculations in pediatric clinical trials conducted in an ICU: a systematic review JO - Trials VL - 15 UR - https://doi.org/10.1186/1745-6215-15-274 DO - 10.1186/1745-6215-15-274 ID - Nikolakopoulos2014 ER - TY - JOUR AU - Joppi, R. AU - Bertele, V. AU - Garattini, S. PY - 2013 DA - 2013// TI - Orphan drugs, orphan diseases. The first decade of orphan drug legislation in the EU JO - Eur J Clin Pharmacol VL - 69 UR - https://doi.org/10.1007/s00228-012-1423-2 DO - 10.1007/s00228-012-1423-2 ID - Joppi2013 ER - TY - BOOK PY - 2005 DA - 2005// TI - Rare diseases: understanding this public health priority ID - ref5 ER - TY - STD TI - Orphanet report series: rare disease registries in Europe - May 2017. http://www.orpha.net/orphacom/cahiers/docs/GB/Registries.pdf. Accessed 30 Apr 2018. UR - http://www.orpha.net/orphacom/cahiers/docs/GB/Registries.pdf ID - ref6 ER - TY - JOUR AU - Bateman, R. J. AU - Benzinger, T. L. AU - Berry, S. AU - Clifford, D. B. AU - Duggan, C. AU - Fagan, A. M. AU - Fanning, K. AU - Farlow, M. R. AU - Hassenstab, J. AU - McDade, E. M. PY - 2017 DA - 2017// TI - The DIAN-TU next generation Alzheimer’s prevention trial: adaptive design and disease progression model JO - Alzheimers Dement VL - 13 UR - https://doi.org/10.1016/j.jalz.2016.07.005 DO - 10.1016/j.jalz.2016.07.005 ID - Bateman2017 ER - TY - JOUR AU - Santoro, M. AU - Coi, A. AU - Lipucci Di Paola, M. AU - Bianucci, A. M. AU - Gainotti, S. AU - Mollo, E. AU - Taruscio, D. AU - Vittozzi, L. AU - Bianchi, F. PY - 2015 DA - 2015// TI - Rare disease registries classification and characterization: a data mining approach JO - Public Health Genomics VL - 18 UR - https://doi.org/10.1159/000369993 DO - 10.1159/000369993 ID - Santoro2015 ER - TY - JOUR AU - Dolk, H. AU - Loane, M. AU - Teljeur, C. AU - Densem, J. AU - Greenlees, R. AU - McCullough, N. AU - Morris, J. AU - Nelen, V. AU - Bianchi, F. AU - Kelly, A. PY - 2015 DA - 2015// TI - Detection and investigation of temporal clusters of congenital anomaly in Europe: seven years of experience of the EUROCAT surveillance system JO - Eur J Epidemiol VL - 30 UR - https://doi.org/10.1007/s10654-015-0012-y DO - 10.1007/s10654-015-0012-y ID - Dolk2015 ER - TY - BOOK AU - Tyczynski, J. E. AU - Démaret, E. AU - Parkin, D. M. PY - 2003 DA - 2003// TI - Standards and guidelines for cancer registration in Europe ID - Tyczynski2003 ER - TY - BOOK AU - Gliklich, R. E. AU - Dreyer, N. AU - Leavy, M. PY - 2014 DA - 2014// TI - Registries for evaluating patient outcomes: a user’s guide ID - Gliklich2014 ER - TY - JOUR AU - Taruscio, D. AU - Mollo, E. AU - Gainotti, S. AU - Posada de la Paz, M. AU - Bianchi, F. AU - Vittozzi, L. PY - 2014 DA - 2014// TI - The EPIRARE proposal of a set of indicators and common data elements for the European platform for rare disease registration JO - Arch Public Health VL - 72 UR - https://doi.org/10.1186/2049-3258-72-35 DO - 10.1186/2049-3258-72-35 ID - Taruscio2014 ER - TY - JOUR AU - Hilgers, R. D. AU - Roes, K. AU - Stallard, N. AU - IdeAl, A. PY - 2016 DA - 2016// TI - directions for new developments on statistical design and analysis of small population group trials JO - Orphanet J Rare Dis VL - 11 UR - https://doi.org/10.1186/s13023-016-0464-5 DO - 10.1186/s13023-016-0464-5 ID - Hilgers2016 ER - TY - JOUR AU - Boers, M. AU - Kirwan, J. R. AU - Wells, G. AU - Beaton, D. AU - Gossec, L. AU - d'Agostino, M. A. AU - Conaghan, P. G. AU - Bingham, C. O. AU - Brooks, P. AU - Landewe, R. PY - 2014 DA - 2014// TI - Developing core outcome measurement sets for clinical trials: OMERACT filter 2.0 JO - J Clin Epidemiol VL - 67 UR - https://doi.org/10.1016/j.jclinepi.2013.11.013 DO - 10.1016/j.jclinepi.2013.11.013 ID - Boers2014 ER - TY - JOUR AU - Tabrizi, S. J. AU - Reilmann, R. AU - Roos, R. A. AU - Durr, A. AU - Leavitt, B. AU - Owen, G. AU - Jones, R. AU - Johnson, H. AU - Craufurd, D. AU - Hicks, S. L. PY - 2012 DA - 2012// TI - Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data JO - Lancet Neurol VL - 11 UR - https://doi.org/10.1016/S1474-4422(11)70263-0 DO - 10.1016/S1474-4422(11)70263-0 ID - Tabrizi2012 ER - TY - JOUR AU - Lauer, M. S. AU - D’Agostino, R. B. PY - 2013 DA - 2013// TI - The randomized registry trial--the next disruptive technology in clinical research? JO - N Engl J Med VL - 369 UR - https://doi.org/10.1056/NEJMp1310102 DO - 10.1056/NEJMp1310102 ID - Lauer2013 ER - TY - JOUR AU - Relton, C. AU - O’Cathain, A. AU - Nicholl, J. PY - 2012 DA - 2012// TI - A pilot ‘cohort multiple randomised controlled trial’ of treatment by a homeopath for women with menopausal hot flushes JO - Contemp Clin Trials VL - 33 UR - https://doi.org/10.1016/j.cct.2012.04.003 DO - 10.1016/j.cct.2012.04.003 ID - Relton2012 ER - TY - STD TI - World Medical Association: Declaration of Helsinki. https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/. Accessed 13 Nov 2017. UR - https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ ID - ref18 ER - TY - BOOK PY - 2016 DA - 2016// TI - ICH E6 Good Clinical Practice (GCP) Guideline ID - ref19 ER - TY - JOUR AU - Kalkman, S. AU - van Thiel, G. AU - Zuidgeest, M. G. P. AU - Goetz, I. AU - Pfeiffer, B. M. AU - Grobbee, D. E. AU - van Delden, J. J. M. PY - 2017 DA - 2017// TI - Series: pragmatic trials and real world evidence: paper 4. Informed consent JO - J Clin Epidemiol VL - 89 UR - https://doi.org/10.1016/j.jclinepi.2017.03.019 DO - 10.1016/j.jclinepi.2017.03.019 ID - Kalkman2017 ER - TY - JOUR AU - Li, G. AU - Sajobi, T. T. AU - Menon, B. K. AU - Korngut, L. AU - Lowerison, M. AU - James, M. AU - Wilton, S. B. AU - Williamson, T. AU - Gill, S. AU - Drogos, L. L. PY - 2016 DA - 2016// TI - Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research? JO - J Clin Epidemiol VL - 80 UR - https://doi.org/10.1016/j.jclinepi.2016.08.003 DO - 10.1016/j.jclinepi.2016.08.003 ID - Li2016 ER - TY - BOOK PY - 2007 DA - 2007// TI - Guideline on clinical trials in small populations ID - ref22 ER - TY - JOUR AU - Moher, D. AU - Hopewell, S. AU - Schulz, K. F. AU - Montori, V. AU - Gotzsche, P. C. AU - Devereaux, P. J. AU - Elbourne, D. AU - Egger, M. AU - Altman, D. G. PY - 2010 DA - 2010// TI - CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials JO - J Clin Epidemiol VL - 63 UR - https://doi.org/10.1016/j.jclinepi.2010.03.004 DO - 10.1016/j.jclinepi.2010.03.004 ID - Moher2010 ER - TY - JOUR AU - van der Ploeg, A. T. AU - Clemens, P. R. AU - Corzo, D. AU - Escolar, D. M. AU - Florence, J. AU - Groeneveld, G. J. AU - Herson, S. AU - Kishnani, P. S. AU - Laforet, P. AU - Lake, S. L. PY - 2010 DA - 2010// TI - A randomized study of alglucosidase alfa in late-onset Pompe’s disease JO - N Engl J Med VL - 362 UR - https://doi.org/10.1056/NEJMoa0909859 DO - 10.1056/NEJMoa0909859 ID - van der Ploeg2010 ER - TY - STD TI - European Medicines Agency: Myozyme, European Public Assessment Report. http://www.ema.europa.eu/ema/index.jsp%3Fcurl%3Dpages/medicines/human/medicines/000636/human_med_000917.jsp%26murl%3Dmenus/medicines/medicines.jsp. Accessed 10 June 2016. UR - http://www.ema.europa.eu/ema/index.jsp%3Fcurl%3Dpages/medicines/human/medicines/000636/human_med_000917.jsp%26murl%3Dmenus/medicines/medicines.jsp ID - ref25 ER - TY - JOUR AU - Nicolino, M. AU - Byrne, B. AU - Wraith, J. E. AU - Leslie, N. AU - Mandel, H. AU - Freyer, D. R. AU - Arnold, G. L. AU - Pivnick, E. K. AU - Ottinger, C. J. AU - Robinson, P. H. PY - 2009 DA - 2009// TI - Clinical outcomes after long-term treatment with alglucosidase alfa in infants and children with advanced Pompe disease JO - Genet Med VL - 11 UR - https://doi.org/10.1097/GIM.0b013e31819d0996 DO - 10.1097/GIM.0b013e31819d0996 ID - Nicolino2009 ER - TY - JOUR AU - Kishnani, P. S. AU - Corzo, D. AU - Nicolino, M. AU - Byrne, B. AU - Mandel, H. AU - Hwu, W. L. AU - Leslie, N. AU - Levine, J. AU - Spencer, C. AU - McDonald, M. PY - 2007 DA - 2007// TI - Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease JO - Neurology VL - 68 UR - https://doi.org/10.1212/01.wnl.0000251268.41188.04 DO - 10.1212/01.wnl.0000251268.41188.04 ID - Kishnani2007 ER - TY - JOUR AU - Byrne, B. J. AU - Kishnani, P. S. AU - Case, L. E. AU - Merlini, L. AU - Muller-Felber, W. AU - Prasad, S. AU - van der Ploeg, A. PY - 2011 DA - 2011// TI - Pompe disease: design, methodology, and early findings from the Pompe registry JO - Mol Genet Metab VL - 103 UR - https://doi.org/10.1016/j.ymgme.2011.02.004 DO - 10.1016/j.ymgme.2011.02.004 ID - Byrne2011 ER - TY - JOUR AU - Kishnani, P. S. AU - Hwu, W. L. AU - Mandel, H. AU - Nicolino, M. AU - Yong, F. AU - Corzo, D. PY - 2006 DA - 2006// TI - A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease JO - J Pediatr VL - 148 UR - https://doi.org/10.1016/j.jpeds.2005.11.033 DO - 10.1016/j.jpeds.2005.11.033 ID - Kishnani2006 ER - TY - STD TI - European Medicines Agency: Myozyme, Scientific discussion. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000636/WC500032128.pdf. Accessed 10 June 2016. UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000636/WC500032128.pdf ID - ref30 ER - TY - STD TI - European Medicines Agency: Defitelio, European Public Assessment Report. http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002393/human_med_001646.jsp&mid=WC0b01ac058001d124. Accessed 10 June 2016. UR - http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/002393/human_med_001646.jsp&mid=WC0b01ac058001d124 ID - ref31 ER - TY - STD TI - European Medicines Agency: Elaprase, European Public Assessment Report. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000700/WC500023003.pdf. Accessed 10 Sept 2017. UR - http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Summary_for_the_public/human/000700/WC500023003.pdf ID - ref32 ER - TY - JOUR AU - Giugliani, R. AU - Hwu, W. L. AU - Tylki-Szymanska, A. AU - Whiteman, D. A. AU - Pano, A. PY - 2014 DA - 2014// TI - A multicenter, open-label study evaluating safety and clinical outcomes in children (1.4-7.5 years) with hunter syndrome receiving idursulfase enzyme replacement therapy JO - Genet Med VL - 16 UR - https://doi.org/10.1038/gim.2013.162 DO - 10.1038/gim.2013.162 ID - Giugliani2014 ER - TY - JOUR AU - Muenzer, J. AU - Jones, S. A. AU - Tylki-Szymanska, A. AU - Harmatz, P. AU - Mendelsohn, N. J. AU - Guffon, N. AU - Giugliani, R. AU - Burton, B. K. AU - Scarpa, M. AU - Beck, M. PY - 2017 DA - 2017// TI - Ten years of the Hunter Outcome Survey (HOS): insights, achievements, and lessons learned from a global patient registry JO - Orphanet J Rare Dis VL - 12 UR - https://doi.org/10.1186/s13023-017-0635-z DO - 10.1186/s13023-017-0635-z ID - Muenzer2017 ER - TY - JOUR AU - Weinreb, N. J. AU - Kaplan, P. PY - 2015 DA - 2015// TI - The history and accomplishments of the ICGG Gaucher registry JO - Am J Hematol VL - 90 UR - https://doi.org/10.1002/ajh.24054 DO - 10.1002/ajh.24054 ID - Weinreb2015 ER - TY - JOUR AU - Weinreb, N. J. AU - Charrow, J. AU - Andersson, H. C. AU - Kaplan, P. AU - Kolodny, E. H. AU - Mistry, P. AU - Pastores, G. AU - Rosenbloom, B. E. AU - Scott, C. R. AU - Wappner, R. S. AU - Zimran, A. PY - 2002 DA - 2002// TI - Effectiveness of enzyme replacement therapy in 1028 patients with type 1 Gaucher disease after 2 to 5 years of treatment: a report from the Gaucher registry JO - Am J Med VL - 113 UR - https://doi.org/10.1016/S0002-9343(02)01150-6 DO - 10.1016/S0002-9343(02)01150-6 ID - Weinreb2002 ER - TY - JOUR AU - Kerem, E. AU - Viviani, L. AU - Zolin, A. AU - MacNeill, S. AU - Hatziagorou, E. AU - Ellemunter, H. AU - Drevinek, P. AU - Gulmans, V. AU - Krivec, U. AU - Olesen, H. PY - 2014 DA - 2014// TI - Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry JO - Eur Respir J VL - 43 UR - https://doi.org/10.1183/09031936.00166412 DO - 10.1183/09031936.00166412 ID - Kerem2014 ER - TY - JOUR AU - Ong, T. AU - Ramsey, B. W. PY - 2015 DA - 2015// TI - Update in cystic fibrosis 2014 JO - Am J Respir Crit Care Med VL - 192 UR - https://doi.org/10.1164/rccm.201504-0656UP DO - 10.1164/rccm.201504-0656UP ID - Ong2015 ER - TY - JOUR AU - O’Sullivan, B. P. AU - Freedman, S. D. PY - 2009 DA - 2009// TI - Cystic fibrosis JO - Lancet VL - 373 UR - https://doi.org/10.1016/S0140-6736(09)60327-5 DO - 10.1016/S0140-6736(09)60327-5 ID - O’Sullivan2009 ER - TY - JOUR AU - Donaldson, S. S. AU - Laningham, F. AU - Fisher, P. G. PY - 2006 DA - 2006// TI - Advances toward an understanding of brainstem gliomas JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.04.6599 DO - 10.1200/JCO.2005.04.6599 ID - Donaldson2006 ER - TY - JOUR AU - Mayhew, A. AU - Mazzone, E. S. AU - Eagle, M. AU - Duong, T. AU - Ash, M. AU - Decostre, V. AU - Vandenhauwe, M. AU - Klingels, K. AU - Florence, J. AU - Main, M. PY - 2013 DA - 2013// TI - Development of the performance of the upper limb module for Duchenne muscular dystrophy JO - Dev Med Child Neurol VL - 55 UR - https://doi.org/10.1111/dmcn.12213 DO - 10.1111/dmcn.12213 ID - Mayhew2013 ER - TY - STD TI - Williamson P, Clarke M. The COMET (Core Outcome Measures in Effectiveness Trials) initiative: its role in improving Cochrane reviews. Cochrane Database Syst Rev. 2012;(4):ED000041. https://doi.org/10.1002/14651858.ED000041. ID - ref42 ER - TY - STD TI - International Consortium for Health Outcomes Measurement: ICHOM initiative. http://www.ichom.org/. Accessed 12 Sept 2016. UR - http://www.ichom.org/ ID - ref43 ER - TY - STD TI - European Commision: European Reference Networks. https://ec.europa.eu/health/ern/policy_en. Accessed 10 Sept 2017. UR - https://ec.europa.eu/health/ern/policy_en ID - ref44 ER - TY - STD TI - U.S. Department of Health and Human Services Food and Drug Administration: Clinical Outcome Assessment Qualification Program https://www.fda.gov/drugs/developmentapprovalprocess/drugdevelopmenttoolsqualificationprogram/ucm284077.htm. Accessed 12 June 2017. UR - https://www.fda.gov/drugs/developmentapprovalprocess/drugdevelopmenttoolsqualificationprogram/ucm284077.htm ID - ref45 ER - TY - BOOK PY - 2005 DA - 2005// TI - Reflection paper on the regulatory guidance for the use of health related quality of life (HRQL)measures in the evaluation of medicinal products ID - ref46 ER - TY - JOUR AU - Viviani, L. AU - Zolin, A. AU - Mehta, A. AU - Olesen, H. V. PY - 2014 DA - 2014// TI - The European cystic fibrosis society patient registry: valuable lessons learned on how to sustain a disease registry JO - Orphanet J Rare Dis VL - 9 UR - https://doi.org/10.1186/1750-1172-9-81 DO - 10.1186/1750-1172-9-81 ID - Viviani2014 ER - TY - BOOK AU - Hardin, J. AU - Hilbe, J. PY - 2003 DA - 2003// TI - Generalized estimating equations PB - Chapman and Hall/CRC CY - London ID - Hardin2003 ER - TY - JOUR AU - Zeger, S. L. AU - Liang, K. Y. PY - 1986 DA - 1986// TI - Longitudinal data analysis for discrete and continuous outcomes JO - Biometrics VL - 42 UR - https://doi.org/10.2307/2531248 DO - 10.2307/2531248 ID - Zeger1986 ER - TY - BOOK PY - 2001 DA - 2001// TI - Note for guidance on choice of control group in clinical trials ID - ref50 ER - TY - JOUR AU - Bouvy, J. C. AU - Blake, K. AU - Slattery, J. AU - De Bruin, M. L. AU - Arlett, P. AU - Kurz, X. PY - 2017 DA - 2017// TI - Registries in European post-marketing surveillance: a retrospective analysis of centrally approved products, 2005-2013 JO - Pharmacoepidemiol Drug Saf VL - 26 UR - https://doi.org/10.1002/pds.4196 DO - 10.1002/pds.4196 ID - Bouvy2017 ER - TY - JOUR AU - Schmitt-Egenolf, M. PY - 2006 DA - 2006// TI - Psoriasis therapy in real life: the need for registries JO - Dermatology VL - 213 UR - https://doi.org/10.1159/000096196 DO - 10.1159/000096196 ID - Schmitt-Egenolf2006 ER - TY - JOUR AU - Hollak, C. E. AU - Aerts, J. M. AU - Ayme, S. AU - Manuel, J. PY - 2011 DA - 2011// TI - Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders JO - Orphanet J Rare Dis VL - 6 UR - https://doi.org/10.1186/1750-1172-6-16 DO - 10.1186/1750-1172-6-16 ID - Hollak2011 ER - TY - JOUR AU - Wilson, I. B. AU - Cleary, P. D. PY - 1995 DA - 1995// TI - Linking clinical variables with health-related quality of life. A conceptual model of patient outcomes JO - JAMA VL - 273 UR - https://doi.org/10.1001/jama.1995.03520250075037 DO - 10.1001/jama.1995.03520250075037 ID - Wilson1995 ER -